International Symposium on Mesothelioma to Focus on Immunotherapy
The eighth annual International Symposium on Malignant Pleural Mesothelioma Saturday at UCLA will reflect the rapidly evolving philosophy on future treatment of this rare cancer.
Change is coming.
The Symposium, which was first held in 2011 to help bring awareness to lung-sparing surgery, will highlight groundbreaking discoveries and the latest advances in immunotherapy and gene therapy — believed to be the future of cancer care.
The longtime chemotherapy and surgery standard-of-care routine is fading.
The symposium at the Luskin Conference Center on the UCLA campus in Los Angeles will help explain why.
“There is so mu...
Source: Asbestos and Mesothelioma News - September 26, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news
IBA receives Brazil's OK for proton therapy system
Proton therapy developer Ion Beam Applications (IBA) has received clearance...Read more on AuntMinnie.comRelated Reading:
IBA wins Singapore contract
Purchase delays affect IBA's 6-month results
IBA lands Ariz. installation
IBA posts mixed 2017 results
IBA posts revenue decreases in Q3 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 19, 2018 Category: Radiology Source Type: news
Hitachi's First Dedicated Compact Proton Therapy System to be Supplied to Tokushukai Medical Group
System will be Installed at Shonan Kamakura Advanced Medical Center, Scheduled to be Complete in September 2020 TOKYO, Sept 14, 2018 - (JCN Newswire) - Hitachi, Ltd. (TSE: 6501) announced today that it has received an order for the compact proton therapy system from Tokushukai Medical Group, and the system will be installed at Shonan Kamakura Advanced Medical Center, which is planned to be built near Shonan Kamakura General Hospital. This is the first order for...This story is related to the following:Radiotherapy Systems (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - September 17, 2018 Category: Medical Devices Source Type: news
Dr. Jeff Balser Named to Varian Board of Directors
PALO ALTO, Calif., Sept. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE : VAR ) today announced that Jeffrey R. Balser, MD, PhD, president and chief executive officer at Vanderbilt University Medical Center and dean of Vanderbilt Unive... Devices, Oncology, Personnel Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2018 Category: Pharmaceuticals Source Type: news
Varian Installs Cyclotron for ProBeam Compact Proton Therapy System at Treatment Center in Florida
PALO ALTO, Calif., Sept. 4, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE : VAR ) today announced the installation of the cyclotron for the Varian ProBeam® Compact single-room proton therapy system at the cancer treatment center on th... Devices, Oncology Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 4, 2018 Category: Pharmaceuticals Source Type: news
Success of proton therapy may depend on who pays for it
The financial success of a proton therapy facility may depend on who pays for...Read more on AuntMinnie.comRelated Reading:
Insurers reverse 97% of pediatric proton denials on appeal
U.S. proton therapy market to reach $1B by 2022
Simple procedures are keys to success of proton facilities (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 30, 2018 Category: Radiology Source Type: news
Purchase delays affect IBA's 6-month results
Proton therapy developer Ion Beam Applications (IBA) is blaming "low revenue...Read more on AuntMinnie.comRelated Reading:
IBA lands Ariz. installation
IBA posts mixed 2017 results
IBA posts revenue decreases in Q3
IBA, Elekta join forces on software development
IBA posts half-year revenue increases (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 23, 2018 Category: Radiology Source Type: news
Proton Therapy Trials'at Risk,' Slow to Enroll Patients Proton Therapy Trials'at Risk,' Slow to Enroll Patients
Is proton therapy better than standard radiotherapy in the treatment of cancer? Seven major randomized clinical trials have no answers at this point.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 12, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Why randomized trials for proton therapy are difficult to complete (and what we can do about it)
(University of Pennsylvania School of Medicine) Commercial insurance medical policies that do not cover treatment with proton therapy can make it difficult for patients to participate in randomized clinical trials funded by the NCI, part of the National Institutes of Health, that are evaluating the therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 11, 2018 Category: International Medicine & Public Health Source Type: news
I'm first person to have proton therapy in the UK
THE first indication there was something wrong came last summer when Simon Hardacre began to feel stressed and run down. Like many men he was inclined to attribute his condition to the wear and tear of life but after encouragement from partner Maria Kose, 40, he went to see a GP. (Source: Daily Express - Health)
Source: Daily Express - Health - July 11, 2018 Category: Consumer Health News Source Type: news
Proton therapy ‘miracle’ treatment allows girl who was blind in one eye to see again
A LITTLE girl who was blinded in one eye has stunned doctors to see again - thanks to miracle treatment in the USA. (Source: Daily Express - Health)
Source: Daily Express - Health - June 29, 2018 Category: Consumer Health News Source Type: news
Latest Evidence for Particle Therapy in NSCLC Latest Evidence for Particle Therapy in NSCLC
What is the latest evidence on proton therapy for locally advanced lung cancer?Translational Lung Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 25, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Mevion secures $150M in financing
Mevion Medical Systems has secured $150 million in financing in a deal...Read more on AuntMinnie.comRelated Reading:
Mevion treats 1st patient with proton therapy system
Mevion nabs FDA OK for proton therapy system
Mevion submits 510(k) to FDA for proton therapy system
Mevion touts scanning milestone
Mevion joins forces with MedPhoton (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 14, 2018 Category: Radiology Source Type: news
Mevion Medical closes $150m funding round
Mevion Medical Systems said today it closed a $150 million financing round with funds slated to support the company’s proton therapy devices and to expand manufacturing.
The round was led by YuanMing Capital and joined by Henan Maisheng Medical Technology and existing investors including HOPU Investments and China Everbright Limited, the Littleton, Mass.-based company said.
Mevion said that funding would be used to support its proton therapy business and to expand the company’s manufacturing capabilities to meet an increased interest in its Hyperscan systems.
Funding will also support the company’s expans...
Source: Mass Device - June 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Funding Roundup Wall Street Beat Mevion Medical Systems Source Type: news
Varian Acquires Taiwan Distributor
PALO ALTO, Calif. and TAIPEI, Taiwan, May 7, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced it has acquired Cooperative CL Enterprises (COOP), a leading distributor of radiotherapy equipment in Taiwan. COOP currentl... Devices, Oncology, Distribution, Mergers & Acquisitions Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 7, 2018 Category: Pharmaceuticals Source Type: news
